Details for: RPL17P34

Gene ID: 643863

Gene Type:  Pseudogene  - A non-functional segment of DNA that resembles a functional gene but has lost its protein-coding ability or is otherwise no longer expressed.

Symbol: RPL17P34

Ensembl ID: ENSG00000213432

Description: ribosomal protein L17 pseudogene 34

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • CD4-positive, alpha-beta thymocyte CL0000810
    CSI 7.7
    rCSI 6.17%
    PRS 98.97

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.
Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [RPL17P34](/details-gene/643863) is a processed pseudogene located on chromosome 10q23.33. As a non-protein-coding gene, it shares high sequence homology with the gene encoding ribosomal protein L17, a component of the 60S large ribosomal subunit. While pseudogenes are often considered non-functional, expression data indicates that [RPL17P34](/details-gene/643863) is transcribed. Analysis across a broad range of human cell types in the **Overall** context reveals a highly specific expression signature, with its most significant presence noted in [CD4-positive, alpha-beta thymocytes](/details-cell/CL0000810). This restricted expression pattern suggests a potential, non-canonical role for its transcript in the developmental processes of T-lymphocytes within the thymus. ## Cellular Roles and Expression Landscape The expression profile of [RPL17P34](/details-gene/643863) is characterized by a high degree of cellular specificity. **Overall**, the gene's most significant expression is found exclusively in [CD4-positive, alpha-beta thymocytes](/details-cell/CL0000810) (CSI: 7.70), which are immature T-cells undergoing selection and maturation in the thymus. The detection of its transcript in these rapidly proliferating and differentiating cells suggests a potential regulatory function associated with T-cell development. Given that [RPL17P34](/details-gene/643863) is a pseudogene and lacks protein-coding potential, its biological role is likely mediated by its RNA transcript. Such transcripts can function as long non-coding RNAs (lncRNAs) involved in gene regulation. The specific expression in thymocytes could indicate a role in modulating the expression of its parent gene, *RPL17*, or other genes critical for ribosome biogenesis to meet the high metabolic demands of T-cell maturation. Without data on its expression in other cell types or different biological contexts, its full landscape remains to be elucidated, but the current evidence points towards a specialized function in T-lymphopoiesis. ## Pathways and Molecular Function As a pseudogene, [RPL17P34](/details-gene/643863) is not annotated in canonical protein function or pathway databases like Gene Ontology or Reactome. It is not translated into a functional protein and therefore does not directly participate in enzymatic reactions or structural complexes. Any molecular function would be attributed to its RNA transcript. Potential functions for pseudogene-derived lncRNAs include: * **Competitive Endogenous RNA (ceRNA):** The [RPL17P34](/details-gene/643863) transcript could act as a "microRNA sponge," binding to and sequestering microRNAs that would otherwise target and repress the mRNA of its functional parent gene, *RPL17*, or other related transcripts. This could serve as a mechanism to fine-tune protein synthesis during thymocyte development. * **Transcriptional Regulation:** The transcript might interact with chromatin-modifying complexes to regulate the expression of nearby or functionally related genes in *cis* or *trans*. * **RNA Stability:** It could potentially form RNA-RNA duplexes with other transcripts, altering their stability or translational efficiency. The functional significance of its expression in thymocytes is likely tied to the intense requirement for protein synthesis during T-cell proliferation and differentiation, where precise control over ribosome biogenesis is critical. ## Research Directions The specific expression of the pseudogene [RPL17P34](/details-gene/643863) in [CD4-positive, alpha-beta thymocytes](/details-cell/CL0000810) opens several avenues for investigation into its potential regulatory roles. **Proposed Hypotheses:** 1. [RPL17P34](/details-gene/643863) functions as a competitive endogenous RNA (ceRNA) in thymocytes, sequestering microRNAs that target the parent *RPL17* gene, thereby post-transcriptionally upregulating ribosome biogenesis to support T-cell maturation. 2. The [RPL17P34](/details-gene/643863) transcript acts as a scaffold for epigenetic modifiers, directly influencing the local chromatin environment at gene loci critical for the CD4+ T-cell lineage commitment. **Experimental Approach:** To test the ceRNA hypothesis (Hypothesis 1), a combination of molecular techniques could be employed. First, RNA immunoprecipitation followed by sequencing (RIP-seq) using an antibody against the Argonaute (AGO2) protein could be performed on lysates from primary human thymocytes. This would identify the specific microRNAs that are loaded into the RISC complex and potentially bind to the [RPL17P34](/details-gene/643863) transcript. Subsequently, CRISPR-interference (CRISPRi) could be used to specifically knockdown the [RPL17P34](/details-gene/643863) transcript in a relevant T-cell precursor model system. The functional consequences would be assessed by measuring the mRNA and protein levels of *RPL17* (via RT-qPCR and Western blot) and by quantifying cellular proliferation and differentiation markers using flow cytometry. **Therapeutic Potential:** The therapeutic potential of [RPL17P34](/details-gene/643863) is speculative but could be relevant in pathologies involving thymocytes, such as T-cell acute lymphoblastic leukemia (T-ALL). If its transcript is shown to be essential for the survival or proliferation of malignant T-cell precursors, it could represent a highly specific target for RNA-based therapies, such as antisense oligonucleotides (ASOs) or siRNAs. The high cell-type specificity of its expression is advantageous, as targeting it would be predicted to have minimal off-target effects on other tissues. This would be a strategy of inhibition, aiming to disrupt a potentially pro-survival regulatory network in cancer cells.